leisure time -WSS

leisure time

author：leisure time 2025-10-02 22:40:50 - browse：11282

BRENDAN SMIALOWSKI/AFP via Getty Images

A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: Zepbound, Valneva's vaccine, and more

focus

WSS

Healthy food access boosts outcomes in two studies

Cancer diagnosis changes perspective doctor, former hospital CEO

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Meta's Zuckerberg and Chan on track to put $50 billion into science

Meta's Zuckerberg and Chan on track to put $50 billion into science

Healthy food access boosts outcomes in two studies

leisure time

leisure time

focus

Affirmative action in medical school literally saved lives

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Affirmative action in medical school literally saved lives

Meta's Zuckerberg and Chan on track to put $50 billion into science

BioMarin wins approval for gene therapy to treat hemophilia A

What is STAT's opinion section for?

Cancer drug shortages should be causing more outrage

Readout Newsletter: What happened with Sarepta's Duchenne data

Medicare proposal to cover medical devices draws a mixed reaction

Experimental asthma app from Apple and Anthem shows promise

Wikipedia

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

First Opinion Podcast: How to protect health care in times of war

What is STAT's opinion section for?

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

What is STAT's opinion section for?

focus

leisure time

explore

Wikipedia